These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 1590912
21. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats. Chang GD, Ramirez VD. Brain Res; 1987 Oct 20; 424(1):49-57. PubMed ID: 3319041 [Abstract] [Full Text] [Related]
22. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B. Ito T, Suzuki K, Uchida K, Nakayama H. Exp Toxicol Pathol; 2012 Nov 20; 64(7-8):761-5. PubMed ID: 21324658 [Abstract] [Full Text] [Related]
24. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation. Fonck C, Baudry M. Brain Res; 2001 Jun 29; 905(1-2):199-206. PubMed ID: 11423095 [Abstract] [Full Text] [Related]
25. A new in vitro approach for investigating the MPTP effect on DA uptake. Barc S, Page G, Fauconneau B, Barrier L, Huguet F. Neurochem Int; 2001 Mar 29; 38(3):243-8. PubMed ID: 11099783 [Abstract] [Full Text] [Related]
26. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro. Chang GD, Ramirez VD. Brain Res; 1986 Mar 12; 368(1):134-40. PubMed ID: 3485463 [Abstract] [Full Text] [Related]
27. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP. Arora PK, Riachi NJ, Fiedler GC, Singh MP, Abdallah F, Harik SI, Sayre LM. Life Sci; 1990 Mar 12; 46(5):379-90. PubMed ID: 2304377 [Abstract] [Full Text] [Related]
28. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes. Scotcher KP, Irwin I, DeLanney LE, Langston JW, Di Monte D. J Neurochem; 1990 Apr 12; 54(4):1295-301. PubMed ID: 2313288 [Abstract] [Full Text] [Related]
30. Quantification of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion in brain tissue by gas chromatography/mass spectrometry. Shih MC, Markey SP. Biomed Environ Mass Spectrom; 1986 Feb 12; 13(2):85-9. PubMed ID: 2937483 [Abstract] [Full Text] [Related]
32. Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain stem of the rat. Desole MS, Miele M, Esposito G, Fresu LG, Migheli R, Zangani D, Sircana S, Grella G, Miele E. Pharmacol Biochem Behav; 1995 Aug 12; 51(4):581-92. PubMed ID: 7675829 [Abstract] [Full Text] [Related]
36. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Herkenham M, Little MD, Bankiewicz K, Yang SC, Markey SP, Johannessen JN. Neuroscience; 1991 Aug 12; 40(1):133-58. PubMed ID: 2052148 [Abstract] [Full Text] [Related]
39. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. Mytilineou C, Cohen G. J Neurochem; 1985 Dec 12; 45(6):1951-3. PubMed ID: 3932598 [Abstract] [Full Text] [Related]
40. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Chiba K, Trevor AJ, Castagnoli N. Biochem Biophys Res Commun; 1985 May 16; 128(3):1228-32. PubMed ID: 3873939 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]